ArticleJournal of cardiovascular electrophysiology2026
Combined Pulsed Field and Radiofrequency Ablation for Coexisting Atrial Tachycardia During or After Atrial Fibrillation Ablation. Interventional and Clinical Outcomes.
Article in Journal of cardiovascular electrophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with atrial fibrillation (AF) may develop atrial tachycardias (ATs) post-ablation or intraprocedurally, especially those with persistent AF or fibrotic substrates. Managing these arrhythmias remains challenging in the pulsed field ablation (PFA) era.
methodsThis prospective study included 56 consecutive patients (mean age 71 ± 8.5 years, 42.9% prior AF ablation) with non-paroxysmal AF or AT and history of AF, who exhibited ≥ 1 left-sided AT during ablation. Targeted intervention of the AT mechanism was performed alongside a prespecified prophylactic lesion set (PPLS), comprising pulmonary vein isolation and posterior wall (PW) ablation via the pentaspline PFA catheter, mitral isthmus (MI) ablation using combined radiofrequency ablation (RFA) and PFA, and cavotricuspid isthmus (CTI) ablation with RFA.
resultsA mean of 1.9 ± 0.9 ATs was identified per patient (48.1% macro-reentry, 20.2% localized reentry, 30.8% unmappable). Acute ablation success at all target sites was 100%. Over a mean follow-up of 20.6 ± 6.6 months (minimum 12), sinus rhythm was maintained in 78.6% of patients after the index procedure and 87.5% after repeat. In nine patients undergoing reintervention, durability was 97.2% for pulmonary veins, 89% for MI linear lesions, and 100% for PW and CTI. Pre-ablation clinical AT (35.7% of patients) significantly predicted non-recurrence (p = 0.021). Interestingly, the inability to achieve successful AT mapping (37.5% of patients) did not negatively influence the clinical outcome.
conclusionIn patients with an AF history and left-sided ATs, a PPLS combined with targeted AT mapping and ablation demonstrates excellent outcomes. Integrating RFA and PFA for MI ablation ensures both acute success and high long-term durability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.